• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 3. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 4. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Branched fatty acids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Branched fatty acids

Recent Advances in the Study of 2-Cyanobutanoic Acid (CAS 51789-75-4) in Chemical Biology and Pharmaceutical Research

2-Cyanobutanoic acid (CAS 51789-75-4) has emerged as a compound of significant interest in chemical biology and pharmaceutical research due to its versatile applications in drug synthesis and biochemical studies. Recent studies have highlighted its role as a key intermediate in the synthesis of various pharmacologically active molecules, including chiral compounds and enzyme inhibitors. This research brief consolidates the latest findings on the synthesis, characterization, and applications of 2-cyanobutanoic acid, providing insights into its potential in drug discovery and development.

A recent study published in the Journal of Medicinal Chemistry explored the enantioselective synthesis of 2-cyanobutanoic acid derivatives using novel catalytic systems. The researchers demonstrated that the compound could be efficiently synthesized with high enantiomeric purity, which is critical for its application in chiral drug development. The study also investigated the compound's stability under physiological conditions, revealing promising results for its use in vivo.

In another groundbreaking study, 2-cyanobutanoic acid was utilized as a precursor for the synthesis of potent enzyme inhibitors targeting metabolic disorders. The research, conducted by a team at Harvard Medical School, showcased the compound's ability to modulate key enzymatic pathways involved in lipid metabolism. These findings open new avenues for the development of therapeutics for conditions such as obesity and diabetes.

Furthermore, advancements in analytical techniques have enabled more precise characterization of 2-cyanobutanoic acid and its derivatives. High-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy have been employed to study the compound's structural properties and interactions with biological targets. These techniques have provided valuable data for optimizing its pharmacological profile.

The pharmaceutical industry has also recognized the potential of 2-cyanobutanoic acid in large-scale drug manufacturing. Recent patents filed by leading pharmaceutical companies highlight its use in streamlined synthetic routes for blockbuster drugs. The compound's cost-effectiveness and scalability make it an attractive candidate for industrial applications.

In conclusion, the latest research on 2-cyanobutanoic acid (CAS 51789-75-4) underscores its importance in chemical biology and pharmaceutical sciences. Its role as a versatile intermediate, coupled with its potential in drug discovery, positions it as a compound of great interest for future studies. Continued exploration of its applications and optimization of synthetic methods will likely yield further breakthroughs in the field.

• 6914-79-0(1-Cyanocyclopropanecarboxylic acid)
• 95658-25-6(Hexanoic acid, 2-cyano-5-methyl-)
• 58160-39-7(Butanedioic acid, 2,3-dicyano-)
• 95658-26-7(Octanoic acid, 2-cyano-)
• 94380-60-6(2-cyanooctadecanoic Acid)
• 57272-21-6(sodium 2-cyano-3,7,11-trimethyldodecanoate)
• 866-29-5( )
• 22426-27-3(2-cyano-3-methylbutanoic acid)
• 88319-38-4(Pentanoic acid, 2-cyano-4,4-dimethyl-)
• 18283-41-5(2-cyano-4-methylpentanoic acid)